“Patients are requiring the use of bronchodilators, antibiotics, and anti-allergics… severe patients are ... Dr Amit Suri, head of the Department, Respiratory Medicine, at the hospital — who is also ...
In 19 of these the arrhythmias were terminated without specific antiarrhythmic therapy after treatment with antibiotics, bronchodilator drugs and intermittent positive-pressure breathing.
A NEW multicenter study, TOReTO, has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in ...
Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. The ...
Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...
Compared with bronchodilator-only relievers, "high certainty" evidence showed that ICS-formoterol was associated with an absolute 10.3% lower risk of severe exacerbations (RR 0.65, 95% CI 0.60-0. ...
Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials ...
A new Review article series, “AI in Medicine,” explores the role of AI technology in clinical medicine and digital health, and examines the promise and pitfalls of its application across the ...